VolitionRx Limited

VolitionRx Limited

$0.66
0 (0.02%)
AMEX
USD, US
Medical - Diagnostics & Research

52 Week Range

0.55-1.57

Beta

1.17

Market Cap

$54.73M

Last Dividend

0

PE (TTM)

-1.55

Dividend Yield (TTM)

0

Price Chart

Industry

Medical - Diagnostics & Research

Sector

Healthcare

CEO

Mr. Cameron Reynolds MBA

Full-Time Employees

108

IPO Date

2012-03-02

Description

VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating samples for more accurate diagnosis; and Nu.Q Discover, a solution to profiling nucleosomes. The company operates Nucleosomics a technology platform for blood test. VolitionRx Limited is based in Austin, Texas.

Phone

646 650 1351

Address

13215 Bee Cave Parkway, Austin, TX, 78738, US

CIK

0000093314